LeMaitre Vascular Inc. (NASDAQ:LMAT)’s share price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $18.85 and last traded at $18.64, with a volume of 113,039 shares changing hands. The stock had previously closed at $18.04.

LMAT has been the topic of several recent analyst reports. Zacks Investment Research raised LeMaitre Vascular from a “hold” rating to a “buy” rating and set a $18.00 price target on the stock in a research note on Thursday, May 5th. Brean Capital reaffirmed a “buy” rating on shares of LeMaitre Vascular in a research report on Tuesday, May 3rd. Canaccord Genuity reaffirmed a “buy” rating and set a $18.00 target price (up from $6.00) on shares of LeMaitre Vascular in a research report on Tuesday, May 3rd. Roth Capital upped their target price on LeMaitre Vascular from $18.00 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, May 3rd. Finally, Barrington Research upped their target price on LeMaitre Vascular from $18.50 to $20.00 and gave the stock an “outperform” rating in a research report on Thursday, July 28th. Seven equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $18.72.

The company has a market capitalization of $339.55 million and a price-to-earnings ratio of 36.93. The company’s 50 day moving average price is $16.22 and its 200-day moving average price is $15.18.

LeMaitre Vascular (NASDAQ:LMAT) last posted its quarterly earnings results on Wednesday, July 27th. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.03. The company had revenue of $22.40 million for the quarter, compared to the consensus estimate of $21.59 million. The business’s revenue for the quarter was up 12.6% on a year-over-year basis. On average, equities research analysts anticipate that LeMaitre Vascular Inc. will post $0.55 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 6th. Investors of record on Monday, August 22nd will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Thursday, August 18th. This represents a $0.18 annualized dividend and a yield of 1.00%.

In other news, Director Lawrence J. Jasinski sold 4,924 shares of LeMaitre Vascular stock in a transaction that occurred on Friday, June 3rd. The stock was sold at an average price of $14.99, for a total value of $73,810.76. Following the sale, the director now directly owns 12,787 shares in the company, valued at approximately $191,677.13. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO George W. Lemaitre sold 6,800 shares of LeMaitre Vascular stock in a transaction that occurred on Wednesday, August 24th. The stock was sold at an average price of $17.49, for a total value of $118,932.00. Following the completion of the sale, the chief executive officer now owns 3,491,564 shares in the company, valued at $61,067,454.36. The disclosure for this sale can be found here.

LeMaitre Vascular, Inc is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.